Calysta Energy

Calysta Energy develops a new biological gas-to-liquids (BioGTL) and biological gas-to-chemicals (BioGTC) technology using natural gas.

Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids (BioGTL) and biological gas-to-chemicals (BioGTC) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.